Holen Sie sich die Stockscreener-App
0.411
5.12%
0.02
Schlusskurs vom Vortag:
$0.391
Offen:
$0.3981
24-Stunden-Volumen:
357.44K
Relative Volume:
0.08
Marktkapitalisierung:
$6.69M
Einnahmen:
$72,100
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-0.6771
EPS:
-0.607
Netto-Cashflow:
$-4.66M
1W Leistung:
+10.19%
1M Leistung:
-17.80%
6M Leistung:
-8.69%
1J Leistung:
-4.17%
1-Tages-Spanne:
$0.391
$0.4338
1-Wochen-Bereich:
$0.36
$0.4338
52-Wochen-Spanne:
$0.221
$1.01
Silo Pharma Inc Stock (SILO) Company Profile
Firmenname
Silo Pharma Inc
Sektor
Branche
Telefon
(718) 400-9031
Adresse
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.40 | 2.93B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
7.50 | 432.93M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.13 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.29 | 288.61M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.54 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser
SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser
Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser
Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowLive Trade Sharing - Newser
Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser
Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SILO Technical Analysis | Trend, Signals & Chart Patterns | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
SILO Silo Pharma reports wider-than-expected Q4 2023 loss, shares dip 1.62% amid weak investor sentiment.High Attention Stocks - Newser
Silo Pharma’S Ptsd Program Advances As FDA Fast-Tracks Psychedelic Therapies For Ptsd - TradingView
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewswire
Why did SILO stock soar 85% today? - MSN
Levi Strauss, Greenbrier and 3 stocks to watch heading into Tuesday - MSN
SILO Silo Pharma rises 5.57 percent despite reporting a wider than expected Q4 2023 per share loss.Gross Margin - Newser
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
SILO Price Today: Silo Pharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Akanda (NASDAQ - Benzinga
Silo Pharma launches AI subsidiary, advances PTSD drug program By Investing.com - Investing.com India
AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition - FinancialContent
Silo Pharma Inc. posts 76.5% EPS miss with no reported revenueDividend Initiation - Cổng thông tin điện tử tỉnh Tây Ninh
Is Southern (SOJD) stock recovering momentum | Q3 2000: Profit SurprisesDecline Phase - Xã Thanh Hà
Silo Pharma launches AI subsidiary, advances PTSD drug program - Investing.com
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - The Manila Times
A biotech advancing a PTSD drug just bought an AI agent platform - Stock Titan
Silo Pharma, Inc. acquired Assets of Qwikagents.ai. - marketscreener.com
Silo Pharma highlights PTSD treatment program amid policy shift By Investing.com - Investing.com India
Silo Pharma highlights PTSD drug program amid policy shift By Investing.com - Investing.com India
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics - marketscreener.com
Silo Pharma (SILO) Stock Payout Ratio (Momentum Building) 2026-04-20Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
Silo Pharma highlights PTSD drug program amid policy shift - Investing.com
Silo Pharma highlights PTSD treatment program amid policy shift - Investing.com
Silo Pharma Positioned to Advance Treatment Targeting PTSD - GlobeNewswire
Silo Pharma (SILO) Stock VWAP Break (+1.18%) 2026-04-18Community Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Is Silo Pharma (SILO) stock a smart investment (Bullish Momentum) 2026-04-18Income Investing - Newser
Finanzdaten der Silo Pharma Inc-Aktie (SILO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Silo Pharma Inc-Aktie (SILO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
| Weisblum Eric | Chief Executive Officer |
May 27 '25 |
Buy |
0.43 |
10,000 |
4,329 |
197,932 |
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):